Although prof. Bounameaux thinks that the new anticoagulants will “revolutionize the treatment of deep vein thrombosis and pulmonary embolism”, he directly mentions some drawbacks.
After a description of the present scheme, he tells about the expected future treatment, based on the RE-COVER and EINSTEIN studies. This requires a good therapeutic education of the patients.
|